ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,262.08
1.38%
Dow Jones
44,296.51
0.97%
Gold vs US Dollar
2,672.37
-1.58%
Brent Oil
74.745
-0.03%
Bitcoin
98,186.00
0.32%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Enzo Biochem Inc (ENZ)

  7. Enzo Biochem Inc (ENZ) News

Enzo Biochem (ENZ)

Enzo Biochem Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:ENZ
DateTimeSourceHeadlineSymbolCompany
29/10/202423:59GlobeNewswire Inc.Enzo Biochem Reports Fourth Quarter and Fiscal Year 2024 Results and Announces Cash DividendNYSE:ENZEnzo Biochem Inc
29/10/202421:04Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:ENZEnzo Biochem Inc
24/09/202421:19Edgar (US Regulatory)Form 8-K - Current reportNYSE:ENZEnzo Biochem Inc
14/08/202420:15Edgar (US Regulatory)Form 8-K - Current reportNYSE:ENZEnzo Biochem Inc
02/08/202420:15Edgar (US Regulatory)Form 8-K - Current reportNYSE:ENZEnzo Biochem Inc
25/07/202421:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ENZEnzo Biochem Inc
25/07/202421:22Edgar (US Regulatory)Form 8-K - Current reportNYSE:ENZEnzo Biochem Inc
24/07/202423:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ENZEnzo Biochem Inc
13/06/202420:20GlobeNewswire Inc.Enzo Biochem Reports Third Quarter Fiscal 2024 Results and Provides Business UpdateNYSE:ENZEnzo Biochem Inc
13/06/202420:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:ENZEnzo Biochem Inc
24/05/202420:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ENZEnzo Biochem Inc
24/05/202420:44Edgar (US Regulatory)Form 8-K - Current reportNYSE:ENZEnzo Biochem Inc
13/03/202420:26GlobeNewswire Inc.Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business UpdateNYSE:ENZEnzo Biochem Inc
28/02/202400:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ENZEnzo Biochem Inc
27/02/202421:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ENZEnzo Biochem Inc
27/02/202421:05Edgar (US Regulatory)Form 8-K - Current reportNYSE:ENZEnzo Biochem Inc
14/02/202415:23Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:ENZEnzo Biochem Inc
13/02/202414:35Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:ENZEnzo Biochem Inc
03/02/202402:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ENZEnzo Biochem Inc
03/02/202402:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ENZEnzo Biochem Inc
03/02/202402:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ENZEnzo Biochem Inc
01/02/202413:33Edgar (US Regulatory)Form 8-K - Current reportNYSE:ENZEnzo Biochem Inc
21/12/202321:48Edgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNYSE:ENZEnzo Biochem Inc
21/12/202321:15Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNYSE:ENZEnzo Biochem Inc
15/12/202321:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:ENZEnzo Biochem Inc
15/12/202321:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ENZEnzo Biochem Inc
28/11/202322:16Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NYSE:ENZEnzo Biochem Inc
03/11/202321:07Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:ENZEnzo Biochem Inc
30/10/202321:01Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:ENZEnzo Biochem Inc
30/10/202320:50Edgar (US Regulatory)Form 8-K - Current reportNYSE:ENZEnzo Biochem Inc
 Showing the most relevant articles for your search:NYSE:ENZ

Your Recent History

LSE
ALBA
Alba Mineral Resources
LSE
EME
Empyrean Energy
LSE
GDR
Genedrive
LSE
TW.
Taylor Wimpey
LSE
ITV
Itv
LSE
ARCM
Arc Minerals
LSE
AAZ
Anglo Asian Mining
LSE
CPX
Cap-xx
LSE
EDEN
Eden Research
LSE
QBT
Quantum Blockchain Techn...
LSE
SRT
Srt Marine Systems
LSE
BARC
Barclays
LSE
VAST
Vast Resources
LSE
SAE
Simec Atlantis Energy
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 60%* for Silver

    1 year 40%, 2 years 50% and *3 years 60%

    *Across 3 years £903.96 only 361.58